Impaired glucose tolerance and fatty liver as predictive factors for biologic switching in patients with psoriatic arthritis
European Journal of Dermatology · 2026-02 · 36 (1) · 59-60
DOI: 10.1684/ejd.2026.5016 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Dermatology, 2026-02. Verfasst von Ken Go und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, St. Marianna University School of Medicine, Kawasaki, Japan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, St. Marianna University School of Medicine, Kawasaki, Japan.
- Department of Dermatology, St. Marianna University School of Medicine, Kawasaki, Japan, Department of Dermatology, St. Marianna University Yokohama City Seibu Hospital, Yokohama, Japan.
Zitieren
APA
Go, K., Miyagaki, T., Nakajima, K., Kadono, T., & Watabe, H. (2026). Impaired glucose tolerance and fatty liver as predictive factors for biologic switching in patients with psoriatic arthritis. European Journal of Dermatology, 36(1), 59-60. https://doi.org/10.1684/ejd.2026.5016
Vancouver
Go K, Miyagaki T, Nakajima K, Kadono T, Watabe H. Impaired glucose tolerance and fatty liver as predictive factors for biologic switching in patients with psoriatic arthritis. European Journal of Dermatology. 2026;36(1):59-60. doi:10.1684/ejd.2026.5016
BibTeX
@article{Go2026,
author = {Go, Ken and Miyagaki, Tomomitsu and Nakajima, Kaori and Kadono, Takafumi and Watabe, Hidenori},
title = {Impaired glucose tolerance and fatty liver as predictive factors for biologic switching in patients with psoriatic arthritis},
journal = {European Journal of Dermatology},
year = {2026},
volume = {36},
number = {1},
pages = {59--60},
doi = {10.1684/ejd.2026.5016}
}
EUVIMED